(Reuters) - Eli Lilly and Co has agreed to acquire Point Biopharma Global in an all-cash deal valued at $1.4 billion, the two companies said on Tuesday.
(Reporting by Leroy Leo in Bengaluru; Editing by Sriraj Kalluvila)
Oil prices were little changed on Wednesday, after falling the previous day, as a dip in U.S. crude stockpiles and expectations of supply disruptions from sanctions on Russian
A half-dozen trade groups from the semiconductor and manufacturing industries sent a private letter to U.S.
The U.S. Securities and Exchange Commission has sued billionaire Elon Musk, saying he failed to disclose his ownership of Twitter stock in a timely manner in early 2022, before buying the social media site
British inflation figures will be closely watched on Wednesday as a sharp jump in government borrowing costs, concerns about domestic and global price pressures and